Skip to content
Home
About Us
Our Story
Programs
KCF-MenToR
Program Overview
KCF-Technology Group
Program Overview
Sessions
Events
Everyday Legends
Spotlight
Rolodex
Resources
Blogs
E-Newsletter
Modules
Get Involved
Contact
Menu
Home
About Us
Our Story
Programs
KCF-MenToR
Program Overview
KCF-Technology Group
Program Overview
Sessions
Events
Everyday Legends
Spotlight
Rolodex
Resources
Blogs
E-Newsletter
Modules
Get Involved
Contact
Upcoming Session on "Understanding the Risks and Benefits of GLP-1 Agonist Drugs for Obesity Treatment and Long-Term Health" | 31st October, 2026 | 8:30 PM IST
ALTAF LAL
KCF Founder
Atlanta Usa
Scroll to Top